<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1988">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04347694</url>
  </required_header>
  <id_info>
    <org_study_id>1357/2020</org_study_id>
    <nct_id>NCT04347694</nct_id>
  </id_info>
  <brief_title>Study to Determine the Immunization Status Among Nephrological Health Care Personnel Against SARS-CoV-2 in a Single Center Over the Course of 12 Months During the Worldwide COVID-19 Pandemic.</brief_title>
  <acronym>CONEC</acronym>
  <official_title>COVID-19 Serology in Nephrology Health Care Workers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Infections with Corona-Viruses have shown to be a menace for patients with comorbidities such
      as hypertension, diabetes, cardiovascular disease or immunosuppression. Those are features
      almost every nephrological patient brings along, especially those on maintenance dialysis and
      those with renal transplant. Since the emergence of the novel coronavirus SARS-CoV-2 in
      November 2019 in Mainland China the fear for pandemic infections has increased. But not only
      is the course of infection itself important, the prevention of transmission to and by
      attending medical personnel should be put into perspective. Thus there is a lack of
      sufficient data of occult immunization or persistent state on immunization.

      In our study up to 400 health care personnel will be screened serologically for IgM, IgA and
      IgG against the SARS-CoV-2 virus. Blood and urine samples throughout 12 months will be
      sampled and analyzed.

      The aim of the study is to identify the rate of occult immunization and at the same time to
      gather data about the persistence of immune response to an infection with SARS-CoV-02. The
      results will help provide sufficient safety measures for health care providers and renal
      patients undergoing unavoidable clinical treatment.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 11, 2020</start_date>
  <completion_date type="Anticipated">April 11, 2021</completion_date>
  <primary_completion_date type="Anticipated">April 11, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Status of Immunization</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">400</enrollment>
  <condition>SARS-CoV 2</condition>
  <condition>Immunization; Infection</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      blood, urine
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Health Care Personnel
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Health Care Personnel and other staff at the Division of Nephrology &amp; Dialysis at the
             Medical

        Exclusion Criteria:

          -  Not matching the inclusion criteria
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas J Reiter, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of Vienna</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Thomas J Reiter, MD</last_name>
    <phone>+43140400</phone>
    <phone_ext>43910</phone_ext>
    <email>thomas.reiter@meduniwien.ac.at</email>
  </overall_contact>
  <location>
    <facility>
      <name>Medical University of Vienna, Division for Nephrology and Dialysis</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas J Reiter, MD</last_name>
      <email>thomas.reiter@meduniwien.ac.at</email>
    </contact>
    <contact_backup>
      <last_name>Gere Sunder-Plassmann, MD</last_name>
      <email>gere.sunder-plassmann@meduniwien.ac.at</email>
    </contact_backup>
    <investigator>
      <last_name>Thomas J Reiter, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>April 12, 2020</study_first_submitted>
  <study_first_submitted_qc>April 14, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 15, 2020</study_first_posted>
  <last_update_submitted>September 1, 2020</last_update_submitted>
  <last_update_submitted_qc>September 1, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Vienna</investigator_affiliation>
    <investigator_full_name>Dr. Thomas Reiter</investigator_full_name>
    <investigator_title>Specialist in Internal Medicine</investigator_title>
  </responsible_party>
  <keyword>Nephrology</keyword>
  <keyword>SARS-CoV-2</keyword>
  <keyword>Vienna</keyword>
  <keyword>Health Care Personnel</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

